BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35076666)

  • 1. Population-Based Penetrance of Deleterious Clinical Variants.
    Forrest IS; Chaudhary K; Vy HMT; Petrazzini BO; Bafna S; Jordan DM; Rocheleau G; Loos RJF; Nadkarni GN; Cho JH; Do R
    JAMA; 2022 Jan; 327(4):350-359. PubMed ID: 35076666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank.
    Biddinger KJ; Jurgens SJ; Maamari D; Gaziano L; Choi SH; Morrill VN; Halford JL; Khera AV; Lubitz SA; Ellinor PT; Aragam KG
    JAMA Cardiol; 2022 Jul; 7(7):715-722. PubMed ID: 35583889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants.
    Shah RA; Asatryan B; Sharaf Dabbagh G; Aung N; Khanji MY; Lopes LR; van Duijvenboden S; Holmes A; Muser D; Landstrom AP; Lee AM; Arora P; Semsarian C; Somers VK; Owens AT; Munroe PB; Petersen SE; Chahal CAA;
    Circulation; 2022 Jul; 146(2):110-124. PubMed ID: 35708014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
    Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
    JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
    Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
    JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors.
    AlDubayan SH; Pyle LC; Gamulin M; Kulis T; Moore ND; Taylor-Weiner A; Hamid AA; Reardon B; Wubbenhorst B; Godse R; Vaughn DJ; Jacobs LA; Meien S; Grgic M; Kastelan Z; Markt SC; Damrauer SM; Rader DJ; Kember RL; Loud JT; Kanetsky PA; Greene MH; Sweeney CJ; Kubisch C; Nathanson KL; Van Allen EM; Stewart DR; Lessel D;
    JAMA Oncol; 2019 Apr; 5(4):514-522. PubMed ID: 30676620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting.
    Wright CF; West B; Tuke M; Jones SE; Patel K; Laver TW; Beaumont RN; Tyrrell J; Wood AR; Frayling TM; Hattersley AT; Weedon MN
    Am J Hum Genet; 2019 Feb; 104(2):275-286. PubMed ID: 30665703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases.
    Zeng C; Bastarache LA; Tao R; Venner E; Hebbring S; Andujar JD; Bland ST; Crosslin DR; Pratap S; Cooley A; Pacheco JA; Christensen KD; Perez E; Zawatsky CLB; Witkowski L; Zouk H; Weng C; Leppig KA; Sleiman PMA; Hakonarson H; Williams MS; Luo Y; Jarvik GP; Green RC; Chung WK; Gharavi AG; Lennon NJ; Rehm HL; Gibbs RA; Peterson JF; Roden DM; Wiesner GL; Denny JC
    JAMA Oncol; 2022 Jun; 8(6):835-844. PubMed ID: 35446370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exome sequencing and characterization of 49,960 individuals in the UK Biobank.
    Van Hout CV; Tachmazidou I; Backman JD; Hoffman JD; Liu D; Pandey AK; Gonzaga-Jauregui C; Khalid S; Ye B; Banerjee N; Li AH; O'Dushlaine C; Marcketta A; Staples J; Schurmann C; Hawes A; Maxwell E; Barnard L; Lopez A; Penn J; Habegger L; Blumenfeld AL; Bai X; O'Keeffe S; Yadav A; Praveen K; Jones M; Salerno WJ; Chung WK; Surakka I; Willer CJ; Hveem K; Leader JB; Carey DJ; Ledbetter DH; ; Cardon L; Yancopoulos GD; Economides A; Coppola G; Shuldiner AR; Balasubramanian S; Cantor M; ; Nelson MR; Whittaker J; Reid JG; Marchini J; Overton JD; Scott RA; Abecasis GR; Yerges-Armstrong L; Baras A
    Nature; 2020 Oct; 586(7831):749-756. PubMed ID: 33087929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Pathogenic DNA Variants Predisposing to Cardiomyopathy With Cardiovascular Disease Outcomes and All-Cause Mortality.
    Patel AP; Dron JS; Wang M; Pirruccello JP; Ng K; Natarajan P; Lebo M; Ellinor PT; Aragam KG; Khera AV
    JAMA Cardiol; 2022 Jul; 7(7):723-732. PubMed ID: 35544052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of polygenic susceptibility to obesity among carriers of pathogenic mutations in MC4R in the UK Biobank population.
    Chami N; Preuss M; Walker RW; Moscati A; Loos RJF
    PLoS Med; 2020 Jul; 17(7):e1003196. PubMed ID: 32692746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Vascular Risk Factors and Genetic Factors With Penetrance of Variants Causing Monogenic Stroke.
    Cho BPH; Harshfield EL; Al-Thani M; Tozer DJ; Bell S; Markus HS
    JAMA Neurol; 2022 Dec; 79(12):1303-1311. PubMed ID: 36300346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Neuropsychiatric Copy Number Variants in a Health Care System Population.
    Martin CL; Wain KE; Oetjens MT; Tolwinski K; Palen E; Hare-Harris A; Habegger L; Maxwell EK; Reid JG; Walsh LK; Myers SM; Ledbetter DH
    JAMA Psychiatry; 2020 Dec; 77(12):1276-1285. PubMed ID: 32697297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss-of-Function Variants in the Tumor-Suppressor Gene
    Olafsdottir T; Stacey SN; Sveinbjornsson G; Thorleifsson G; Norland K; Sigurgeirsson B; Thorisdottir K; Kristjansson AK; Tryggvadottir L; Sarin KY; Benediktsson R; Jonasson JG; Sigurdsson A; Jonasdottir A; Kristmundsdottir S; Jonsson H; Gylfason A; Oddsson A; Fridriksdottir R; Gudjonsson SA; Zink F; Lund SH; Rognvaldsson S; Melsted P; Steinthorsdottir V; Gudmundsson J; Mikaelsdottir E; Olason PI; Stefansdottir L; Eggertsson HP; Halldorsson BV; Thorsteinsdottir U; Agustsson TT; Olafsson K; Olafsson JH; Sulem P; Rafnar T; Gudbjartsson DF; Stefansson K
    Cancer Res; 2021 Apr; 81(8):1954-1964. PubMed ID: 33602785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian approach to determining penetrance of pathogenic SDH variants.
    Benn DE; Zhu Y; Andrews KA; Wilding M; Duncan EL; Dwight T; Tothill RW; Burgess J; Crook A; Gill AJ; Hicks RJ; Kim E; Luxford C; Marfan H; Richardson AL; Robinson B; Schlosberg A; Susman R; Tacon L; Trainer A; Tucker K; Maher ER; Field M; Clifton-Bligh RJ
    J Med Genet; 2018 Nov; 55(11):729-734. PubMed ID: 30201732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of Cancer Risk Profile for BRCA1 and BRCA2 Pathogenic Variants.
    Momozawa Y; Sasai R; Usui Y; Shiraishi K; Iwasaki Y; Taniyama Y; Parsons MT; Mizukami K; Sekine Y; Hirata M; Kamatani Y; Endo M; Inai C; Takata S; Ito H; Kohno T; Matsuda K; Nakamura S; Sugano K; Yoshida T; Nakagawa H; Matsuo K; Murakami Y; Spurdle AB; Kubo M
    JAMA Oncol; 2022 Jun; 8(6):871-878. PubMed ID: 35420638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma.
    AlDubayan SH; Conway JR; Camp SY; Witkowski L; Kofman E; Reardon B; Han S; Moore N; Elmarakeby H; Salari K; Choudhry H; Al-Rubaish AM; Al-Sulaiman AA; Al-Ali AK; Taylor-Weiner A; Van Allen EM
    JAMA; 2020 Nov; 324(19):1957-1969. PubMed ID: 33201204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma.
    Salviat F; Gauthier-Villars M; Carton M; Cassoux N; Lumbroso-Le Rouic L; Dehainault C; Levy C; Golmard L; Aerts I; Doz F; Bonnet-Serrano F; Hayek S; Savignoni A; Stoppa-Lyonnet D; Houdayer C
    JAMA Ophthalmol; 2020 Aug; 138(8):843-850. PubMed ID: 32556071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary variants in individuals undergoing exome sequencing: screening of 572 individuals identifies high-penetrance mutations in cancer-susceptibility genes.
    Johnston JJ; Rubinstein WS; Facio FM; Ng D; Singh LN; Teer JK; Mullikin JC; Biesecker LG
    Am J Hum Genet; 2012 Jul; 91(1):97-108. PubMed ID: 22703879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced penetrance of pathogenic ACMG variants in a deeply phenotyped cohort study and evaluation of ClinVar classification over time.
    van Rooij J; Arp P; Broer L; Verlouw J; van Rooij F; Kraaij R; Uitterlinden A; Verkerk AJMH
    Genet Med; 2020 Nov; 22(11):1812-1820. PubMed ID: 32665702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.